DB
CLBT icon

Dmitry Balyasny’s Cellebrite CLBT Stock Holding History

Dmitry Balyasny’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-238,181
Closed -$3.81M – 2974
2025
Q2 		$3.81M Buy
+238,181
New +$4.25M 0.01% 1415
2024
Q1 		– Sell
-87,376
Closed -$757K – 2676
2023
Q4 		$757K Buy
87,376
+63,676
+269% +$495K ﹤0.01% 1795
2023
Q3 		$181K Buy
+23,700
New +$178K ﹤0.01% 2048

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Dmitry Balyasny's CLBT Position: Q3 2025 in Review

Dmitry Balyasny sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 238,181 shares — an estimated $3.81M sold.

Dmitry Balyasny first reported a position in CLBT in Q3 2023 and held it in 3 quarters. The position peaked at $3.81M in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Dmitry Balyasny reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Dmitry Balyasny sold 238,181 Cellebrite shares in Q3 2025, an estimated $3.81M.
  • Dmitry Balyasny first reported a position in Cellebrite in Q3 2023 and held it in 3 quarters.
  • Dmitry Balyasny's Cellebrite position peaked at $3.81M in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.